Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2005 2
2006 2
2007 2
2008 2
2009 1
2010 1
2011 4
2012 7
2013 5
2014 5
2015 5
2016 9
2017 3
2018 4
2019 4
2020 5
2021 4
2022 12
2023 18
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean chien hsing l (1 results)?
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.
Makker V, Colombo N, Casado Herráez A, Santin AD, Colomba E, Miller DS, Fujiwara K, Pignata S, Baron-Hay S, Ray-Coquard I, Shapira-Frommer R, Ushijima K, Sakata J, Yonemori K, Kim YM, Guerra EM, Sanli UA, McCormack MM, Smith AD, Keefe S, Bird S, Dutta L, Orlowski RJ, Lorusso D; Study 309–KEYNOTE-775 Investigators. Makker V, et al. N Engl J Med. 2022 Feb 3;386(5):437-448. doi: 10.1056/NEJMoa2108330. Epub 2022 Jan 19. N Engl J Med. 2022. PMID: 35045221 Clinical Trial.
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.
Colombo N, Dubot C, Lorusso D, Caceres MV, Hasegawa K, Shapira-Frommer R, Tewari KS, Salman P, Hoyos Usta E, Yañez E, Gümüş M, Olivera Hurtado de Mendoza M, Samouëlian V, Castonguay V, Arkhipov A, Toker S, Li K, Keefe SM, Monk BJ; KEYNOTE-826 Investigators. Colombo N, et al. N Engl J Med. 2021 Nov 11;385(20):1856-1867. doi: 10.1056/NEJMoa2112435. Epub 2021 Sep 18. N Engl J Med. 2021. PMID: 34534429 Clinical Trial.
Survival with Cemiplimab in Recurrent Cervical Cancer.
Tewari KS, Monk BJ, Vergote I, Miller A, de Melo AC, Kim HS, Kim YM, Lisyanskaya A, Samouëlian V, Lorusso D, Damian F, Chang CL, Gotovkin EA, Takahashi S, Ramone D, Pikiel J, Maćkowiak-Matejczyk B, Guerra Alía EM, Colombo N, Makarova Y, Rischin D, Lheureux S, Hasegawa K, Fujiwara K, Li J, Jamil S, Jankovic V, Chen CI, Seebach F, Weinreich DM, Yancopoulos GD, Lowy I, Mathias M, Fury MG, Oaknin A; Investigators for GOG Protocol 3016 and ENGOT Protocol En-Cx9. Tewari KS, et al. N Engl J Med. 2022 Feb 10;386(6):544-555. doi: 10.1056/NEJMoa2112187. N Engl J Med. 2022. PMID: 35139273 Clinical Trial.
Targeting HSF1 for cancer treatment: mechanisms and inhibitor development.
Chin Y, Gumilar KE, Li XG, Tjokroprawiro BA, Lu CH, Lu J, Zhou M, Sobol RW, Tan M. Chin Y, et al. Among authors: lu ch. Theranostics. 2023 Apr 17;13(7):2281-2300. doi: 10.7150/thno.82431. eCollection 2023. Theranostics. 2023. PMID: 37153737 Free PMC article. Review.
Metronomic therapy for gynecologic cancers.
Su WH, Ho TY, Li YT, Lu CH, Lee WL, Wang PH. Su WH, et al. Among authors: lu ch. Taiwan J Obstet Gynecol. 2012 Jun;51(2):167-78. doi: 10.1016/j.tjog.2012.04.002. Taiwan J Obstet Gynecol. 2012. PMID: 22795090 Free article. Review.
The Current Trend of Fertility Preservation in Patients with Cervical Cancer.
Liu CK, Huang KG, Chen MJ, Lu CH, Hwang SF, Sun L, Hsu ST. Liu CK, et al. Among authors: lu ch. Gynecol Minim Invasive Ther. 2023 Dec 7;13(1):4-9. doi: 10.4103/gmit.gmit_34_23. eCollection 2024 Jan-Mar. Gynecol Minim Invasive Ther. 2023. PMID: 38487609 Free PMC article. Review.
90 results